gimli
JUBLPHARMA stock analysis context
JUBILANT PHARMOVA Stock Context for AI Screening
JUBILANT PHARMOVA LTD is a mid-cap stock in Healthcare. This page summarizes key screening signals for JUBILANT PHARMOVA, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about JUBLPHARMAPrice
₹1,006.35
1M return
+8.45%
3M return
+15.33%
Market cap
₹15,939.30 cr
PE
38.57
ROE
+7.09%
RSI
65.99
Turnover
₹53.52 cr
Why it can matter in screens
- Momentum: JUBLPHARMA is above 50DMA; RSI is 65.99.
- Returns: 1M +8.45%, 3M +15.33%, 6M -4.86%.
- Liquidity: latest turnover is ₹53.52 cr.
- Valuation: PE 38.57, PB n/a, ROE +7.09%, ROCE +8.62%.
- Growth: 3Y sales CAGR +5.88%, 3Y profit CAGR +26.57%.
Try these prompts
- Analyze JUBILANT PHARMOVA with valuation, momentum and industry peers
- Compare JUBLPHARMA with other Healthcare stocks
- Show mid-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View mid-cap stocks
- Find stocks above 50DMA
- Compare JUBLPHARMA with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.